Files
Download Full Text (346 KB)
Description
Pediatric chronic pain has seen a disturbing rise which ends up affecting the child’s routine and impacting their family’s lives. Medical cannabis has Food and Drug Administration-approved derivatives, yet the studies that focus on medical cannabis do not discuss targeting pain in pediatric patients. Children who experience chronic diseases and treatment-resistant pain are not normally offered medical cannabis as a treatment option which needs to change. The purpose of this paper is to explore the impact of medical cannabis within the pediatric population. If children experience pain that is similar to adults, withholding techniques that can help alleviate their pain should be avoided. The study will assess how pediatric patients adapt to medical cannabis. The proposed research design is a quantitative, test-retest study focused on pediatric patients who are 3-12 years old and have been diagnosed with a chronic disease, treatment-resistant pain, or both. There will be a collaboration with Bay Area pediatric outpatient offices. The study will use the Wong-Baker Faces Pain Rating Scale and Likert Scale. There are many ethical considerations surrounding this study since pediatric patients are a vulnerable population due to their varying mental capacities. Post-treatment, patients and parents will re-evaluate pain and daily living. Statistical analysis will help identify areas for further research regarding different demographics. The results are anticipated to provide valuable contributions to pediatric pain management.
Department
Nursing
Publication Date
2023
Sponsorship/Conference/Institution
Dominican University of California
City
San Rafael, CA
Keywords
marijuana, children or adolescents, pain management, epilepsy, irritable bowl diseases, treatment resistant pain
Disciplines
Nursing | Pediatric Nursing | Pediatrics